Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Ramadan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Pharmacotherapy|September 1, 1995
Age and carotid artery occlusive disease are important determinants of cerebral blood flow changes after antihypertensive therapyS C Fagan, S R Levine, J R Ewing, et al.
Journal of Cardiovascular Pharmacology|July 1, 1996
Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive diseaseR V Patel, N M Ramadan, S R Levine, et al.
Cephalalgia : an International Journal of Headache|January 24, 2006
Factors determining headache at onset of acute ischemic strokeP D Mitsias, N M Ramadan, S R Levine, et al.
Journal of Neonatal-Perinatal Medicine|March 23, 2016
Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of lifeM S El Shemi, M H Mohamed, A O AbdelRahman, et al.
Pharmacotherapy|January 1, 1992
Cerebral blood flow changes with enalaprilS C Fagan, S Robert, J R Ewing, et al.
Headache|July 1, 1989
Low brain magnesium in migraineN M Ramadan, H Halvorson, A Vande-Linde, et al.
Headache|October 1, 1989
Low brain magnesium in migraineN M Ramadan, H Halvorson, A Vande-Linde, et al.
Neurology|December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study GroupG D Solomon, R K Cady, J A Klapper, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusionS C Fagan, J R Ewing, S R Levine, et al.
Neurology|December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study GroupA M Rapoport, N M Ramadan, J U Adelman, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pharmacotherapy|September 1, 1995
Age and carotid artery occlusive disease are important determinants of cerebral blood flow changes after antihypertensive therapyS C Fagan, S R Levine, J R Ewing, et al.
Journal of Cardiovascular Pharmacology|July 1, 1996
Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive diseaseR V Patel, N M Ramadan, S R Levine, et al.
Cephalalgia : an International Journal of Headache|January 24, 2006
Factors determining headache at onset of acute ischemic strokeP D Mitsias, N M Ramadan, S R Levine, et al.
Journal of Neonatal-Perinatal Medicine|March 23, 2016
Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of lifeM S El Shemi, M H Mohamed, A O AbdelRahman, et al.
Pharmacotherapy|January 1, 1992
Cerebral blood flow changes with enalaprilS C Fagan, S Robert, J R Ewing, et al.
Headache|July 1, 1989
Low brain magnesium in migraineN M Ramadan, H Halvorson, A Vande-Linde, et al.
Headache|October 1, 1989
Low brain magnesium in migraineN M Ramadan, H Halvorson, A Vande-Linde, et al.
Neurology|December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study GroupG D Solomon, R K Cady, J A Klapper, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1991
Assessing the effects of antihypertensive medication on cerebral blood flow: demonstration in internal carotid artery occlusionS C Fagan, J R Ewing, S R Levine, et al.
Neurology|December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study GroupA M Rapoport, N M Ramadan, J U Adelman, et al.
Pageof 6